Breast conservation after neoadjuvant chemotherapy: the MD Anderson Cancer Center experience

By  

The Women's Oncology Review, Vol. 4, Iss. 3, 2004-09 ,pp. : 225-227

Informa Healthcare

Access to resources Recommend Favorite

Phase I/II trial of high dose mitoxantrone in metastatic breast cancer: the M.D. Anderson Cancer Center experience

By Cristofanilli M.   Holmes F.A.   Esparza L.   Valero V.   Buzdar A.U.   Neidhart J.A.   Hortobagyi G.N.  

Breast Cancer Research and Treatment, Vol. 54, Iss. 3, 1999-04 ,pp. : 225-233

Springer Publishing Company

Access to resources Recommend Favorite

Breast conservation after neoadjuvant chemotherapy: A prognostic index for clinical decision-making

By Holmes Dennis  

The Women's Oncology Review, Vol. 5, Iss. 2, 2005-06 ,pp. : 129-130

Informa Healthcare

Access to resources Recommend Favorite

Multidisciplinary approach to cancer treatment: a model for breast cancer treatment at the M.D. Anderson Cancer Center

By Kim Ryungsa   Toge Tetsuya  

International Journal of Clinical Oncology, Vol. 9, Iss. 5, 2004-10 ,pp. : 356-363

Springer Publishing Company

Access to resources Recommend Favorite

Functional proteomics characterization of residual breast cancer after neoadjuvant systemic chemotherapy

By Gonzalez-Angulo A. M.   Liu S.   Chen H.   Chavez-MacGregor M.   Sahin A.   Hortobagyi G. N.   Mills G. B.   Do K.-A.   Meric-Bernstam F.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 909-916

Oxford University Press

Access to resources Recommend Favorite